|Bid||15.23 x 1200|
|Ask||15.28 x 1000|
|Day's Range||15.00 - 15.50|
|52 Week Range||4.16 - 16.30|
|Beta (5Y Monthly)||1.78|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) shareholders will have a reason to smile today, with the analysts making...
Investors in Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) had a good week, as its shares rose 5.4% to close at US$14.60...
Marinus Pharmaceuticals (MRNS) delivered earnings and revenue surprises of 17.74% and -100.00%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?